ObjectivesPreeclampsia is a hypertensive disorder associated with pregnancy and is the leading cause of both maternal and neonatal morbidity and mortality. Recent reports suggest that free radical-induced endothelial cell injury might be an etiologic factor in the pathogenesis of preeclampsia. The aim of this study was to determine the protective effects of vitamins C and E for the prevention of preeclampsia.MethodsThis clinical trial was conducted in the year 2018 in the clinical centers of Lorestan University of Medical Sciences. One hundred and sixty nulliparous women aged 18–38 years without any risk factors for preeclampsia were divided into two groups. The first group received a 400-IU/day dose of vitamin E orally and a 1000-mg/day dose of vitamin C with iron tablets during 20–24 weeks of pregnancy, while the control group received only iron tablets. Finally, the data were analyzed using descriptive statistics and frequency distribution tables.ResultsThe incidence of preeclampsia in the control group was 17.5% and in the intervention group was 5%, which was significantly different. The mean systolic pressures before and after intervention were 99.43 ± 7.8 and 12.44 ± 19.1, respectively, in the control group, and 99.3 ± 8.3 and 106.12 ± 13.25, respectively, in the intervention group (P < 0.001). The mean diastolic pressures before and after intervention in the control group were 62.7 ± 13.6 and 62.7 ± 4.7 (P < 0.001), respectively.ConclusionThe results of this study show that vitamins C and E have protective effects against preeclampsia by alleviating the overall blood pressure.

Genital herpes is one of the sexually transmitted diseases that is reported with a greater incidence of primary and secondary recurrence. In this study, olive leaf extract was used for its antiviral properties to treat the infection. The randomized‐clinical trials using such a therapeutic approach are required in this field.

No abstract

: Over the years, the efficacy of assisted reproductive technologies has significantly improved. Infertility-associated problems like tubal obstruction, severe male-factor infertility, severe endometriosis and ovulatory dysfunction have entailed the need of in vitro fertilization (IVF). Intracytoplasmic sperm injection (ICSI) is the insertion of a single and viable spermatozoon into the oocyte, thereby circumventing the penetration of the oocyte membranes and aiding gamete fusion process. The use of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) are most commonly practiced therapeutic measures. However, owing to the report-based outcomes, the success rate is still inconclusive. In addition, there are reports on low pregnancy rates after ICSI, using round spermatids from men, in the absence of elongated spermatids in testes. The use of elongated and round spermatids in ICSI procedures has raised some reasonable doubts regarding the safety of this treatment. In this review, we will give a comprehensive discussion on the role of IVF/ICSI for the treatment of infertility, based on the current researches.